Preparation and characterization of novel magnetic nano-in-microparticles for site-specific pulmonary drug delivery

Molecular Pharmaceutics

Volumn 10, Issue 10, 2013, Pages 3574-3581

  McBride, Amber A ^a,b,c   Price, Dominique N ^a,b   Lamoureux, Loreen R ^a   Elmaoued, Alaa A ^a,b   Vargas, Jose M ^d   Adolphi, Natalie L ^b   Muttil, Pavan ^a,b,c  

^a UNIVERSITY OF NEW MEXICO   (United States)

^b UNIVERSITY OF NEW MEXICO HEALTH SCIENCES CENTER   (United States)

^c UNIVERSITY OF NEW MEXICO   (United States)

^d UNIVERSITY OF NEW ORLEANS   (United States)

Author keywords

Inhalable dry powders; Lung cancer therapy; Magnetic microparticles; Pulmonary delivery; SPIONs; Spray drying

Indexed keywords

DOXORUBICIN; SUPERPARAMAGNETIC IRON OXIDE NANOPARTICLE;

ARTICLE; ATOMIC EMISSION SPECTROMETRY; CANCER CHEMOTHERAPY; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG INDICATION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HYDRODYNAMICS; LASER DIFFRACTION; LIGHT SCATTERING; LUNG CANCER; MAGNETIC FIELD; PRIORITY JOURNAL; ROENTGEN SPECTROSCOPY; SCANNING ELECTRON MICROSCOPY; SPRAY DRYING; SURFACE PROPERTY; TRANSMISSION ELECTRON MICROSCOPY; ZETA POTENTIAL;

ADMINISTRATION, INHALATION; DRUG DELIVERY SYSTEMS; FERRIC COMPOUNDS; LUNG; MAGNETICS; NANOPARTICLES; PARTICLE SIZE; TRACHEA;

EID: 84888378566     PISSN: 15438384     EISSN: 15438392     Source Type: Journal    
DOI: 10.1021/mp3007264     Document Type: Article

References (24)

1. Jemal, A.; Bray, F.; Center, M.; Ferlay, J.; Ward, E.; Forman, D. Global cancer statistics. CA-Cancer J. Clin. 2011, 61, 69-90.
2. American Lung Association. Lung Cancer Facts and Figures; 2012. http://www.lung.org/lung-disease/lung-cancer/resources/factsfigures/ lung-cancer-fact-sheet.html.
3. Krapcho, M.; Neyman, N.; Aminou, R.; Howlader, N. SEER Cancer Statistics Review, 1975.2006; National Cancer Institute: Bethesda, MD, 2009.
4. Minchinton, A. I.; Tannock, I. F. Drug penetration in solid tumours. Nat. Rev. Cancer 2006, 6, 583-592.
5. Gehr, P.; Bachofen, M.; Weibel, E. R. The normal human lung: ultrastructure and morphometric estimation of diffusion capacity. Respir. Physiol. 1978, 32, 121-140.
6. Hershey, A. E.; Kurzman, I.; Forrest, L.; Bohling, C.; Stonerook, M.; Placke, M.; Imondi, A.; Vail, M. Inhalation chemotherapy for macroscopic primary or metastatic lung tumors: proof of principle using dogs with spontaneously occurring tumors as a model. Clin. Cancer Res. 1999, 5, 2653-9.
7. Otterson, G. A.; Vilalona-Calero, M.; Sharma, S.; Kris, M.; Imondi, A.; Gerber, M.; White, D.; Ratain, M.; Schiler, J. Sandler. Phase I study of inhaled Doxorubicin for patients with metastatic tumors to the lungs. Clin. Cancer Res. 2007, 13, 1246-1252.
8. Otterson, G. A.; Villalona-Calero, M.; Hicks, W.; Pan, X.; Elleron, J.; Gettinger, S.; Murren, J. Phase I/II study of inhaled doxorubicin combined with platinum-based therapy for advanced non-small cell lung cancer. Clin. Cancer Res. 2010, 16, 2466-2473.
9. Xie, Y.; Longest, P. W.; Xu, Y. H.; Wang, J. P.; Wiedmann, T. S. In vitro and in vivo lung deposition of coated magnetic aerosol particles. J. Pharm. Sci. 2010, 99, 4658-4668.
10. Ally, J.; Amirfazli, A. Chapter 28: Targeting Magnetic Particles for Drug Deliver. In Handbook of Nanophysics: Nanomedicine and Nanorobotics, Sattler, K., Ed.; CRC Press: Boca Raton, 2010; pp 1-17.
11. Dames, P.; Gleich, B.; Flemmer, A.; Hajek, K.; Seidl, N.; Wiekhorst, F.; Eberbeck, D.; Bittmann, I.; Bergemann, C.; Weyh, T.; Trahms, L.; Rosenecker, J.; Rudolph, C. Targeted delivery of magnetic aerosol droplets to the lung. Nat. Nanotechnol. 2007, 2, 495-499.
12. Rudolph, C.; Gleich, B.; Flemmer, A. W. Magnetic aerosol targeting of nanoparticles to cancer: nanomagnetosols. Methods Mol. Biol. 2010, 624, 267-280.
13. McBride, A.; Lamoureux, L.; Price, D.; Muttil, P. Novel Preparation and Characterization of Magnetic Nano-in-Microparticle Dry Powders for Directed Drug Delivery: An Application to Lung Cancer. Respir. Drug Delivery Conf. 2012 2012, 3, 815-820.
14. Mikan, A.; Martinez Lanao, J.; Gonzalez Lopez, F.; Dominguez-Gil Hurle, A. High performance liquid chromatography determination of doxorubicin and daunorubicin in plasma using UV detection and column switching. Biomed. Chromatogr. 1990, 4, 154-156.
15. Urva, S. R.; Shin, B. S.; Yang, V. C.; Balthasar, J. P. Sensitive high performance liquid chromatographic assay for assessment of doxorubicin pharmacokinetics in mouse plasma and tissues. J. Chromatogr., B: Anal. Technol. Biomed. Life Sci. 2009, 877, 837-841.
16. Son, Y.; Mitchell, J.; McConville, J. In Vitro Performance Testing for Pulmonary Drug Delivery. In Controlled pulmonary drug delivery, 1st ed.; Smyth, H., Hickey, A.; Springer Publishing Co.: New York, 2011; pp 383-415.
17. Zak, A.; Feldman, Y.; Lyakhovitskaya, V.; Leitus, G.; Popovitz-Biro, R.; Wachtel, E.; Cohen, H.; Reich, S.; Tenne, R. Alkali metal intercalated fullerene-like MS2 (M= W, Mo) nanoparticles and their properties. J. Am. Chem. Soc. 2002, 124, 4747-4758.
18. Tatsumura, T.; Yamamoto, K.; Murakami, A. New chemotherapeutic method for the treatment of tracheal and bronchial cancers.nebulization chemotherapy. Gan No Rinsho 1983, 7, 765-70.
19. Louey, M. D.; Van Oort, M.; Hickey, A. J. Aerosol dispersion of respirable particles in narrow size distributions using drug-alone and lactose-blend formulations. Pharm. Res. 2004, 21, 1207-1213.
20. Arruebo, M.; Fernández-Pacheco, R.; Ibarra, M. R. Magnetic nanoparticles for drug delivery. Nano Today 2007, 3, 22-32.
21. Gupta, A. K.; Gupta, M. Synthesis and surface engineering of iron oxide nanoparticles for biomedical applications. Biomaterials 2005, 26, 3995-4021.
22. Gleich, B.; Hellwig, N.; Bridell, H.; Jurgons, R. IEEE Xplore-Design and Evaluation of Magnetic Fields for Nanoparticle Drug Targeting in Cancer. Nanotechnology 2007, 6, 164-170.
23. Strable, E.; Bulte, J.; Moskowitz, B. Synthesis and characterization of soluble iron oxide-dendrimer composites. Chem. Mater. 2001, 13, 2201-2209.
24. Hasenpusch, G.; Geiger, J.; Wagner, K.; Mykhaylyk, O.; Wiekhorst, F.; Trahms, L.; Heidsieck, A.; Gleich, B.; Rudolph, C. Magnetized Aerosols Comprising Superparamagnetic Iron Oxide Nanoparticles Improve Targeted Drug and Gene Delivery to the Lung. Pharm. Res. 2012, 29, 1308-18.